These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Management of postmenopausal osteoporosis and the prevention of fractures. Gambacciani M; Levancini M Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322 [TBL] [Abstract][Full Text] [Related]
6. Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture. Ettinger B; Stuenkel CA; Schnatz PF Menopause; 2013 Oct; 20(10):1092-7. PubMed ID: 24048261 [TBL] [Abstract][Full Text] [Related]
8. Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Simon JA; Recknor C; Moffett AH; Adachi JD; Franek E; Lewiecki EM; McClung MR; Mautalen CA; Ragi-Eis S; Nicholson GC; Muschitz C; Nuti R; Törring O; Wang A; Libanati C Menopause; 2013 Feb; 20(2):130-7. PubMed ID: 23010883 [TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis]. Uelbelhart B; Rizzoli R Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820 [TBL] [Abstract][Full Text] [Related]
11. New developments in the treatment of osteoporosis. Eriksen EF; Halse J; Moen MH Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526 [TBL] [Abstract][Full Text] [Related]
12. Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis. McClung MR; Zanchetta JR; Høiseth A; Kendler DL; Yuen CK; Brown JP; Stonkus S; Goemaere S; Recknor C; Woodson GC; Bolognese MA; Franek E; Brandi ML; Wang A; Libanati C J Clin Densitom; 2013; 16(2):250-6. PubMed ID: 22572531 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. Eastell R; Rosen CJ; Black DM; Cheung AM; Murad MH; Shoback D J Clin Endocrinol Metab; 2019 May; 104(5):1595-1622. PubMed ID: 30907953 [TBL] [Abstract][Full Text] [Related]
14. Drugs for postmenopausal osteoporosis. Med Lett Drugs Ther; 2020 Jul; 62(1602):105-112. PubMed ID: 32728009 [No Abstract] [Full Text] [Related]
15. Postmenopausal Osteoporosis: A Clinical Review. Watts NB J Womens Health (Larchmt); 2018 Sep; 27(9):1093-1096. PubMed ID: 29583083 [TBL] [Abstract][Full Text] [Related]
16. Efficacy, effectiveness and side effects of medications used to prevent fractures. Reid IR J Intern Med; 2015 Jun; 277(6):690-706. PubMed ID: 25495429 [TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of osteoporosis]. Fassbender WJ; Willmann B Dtsch Med Wochenschr; 2014 Mar; 139(10):497-500. PubMed ID: 24570199 [No Abstract] [Full Text] [Related]
18. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Josse R; Khan A; Ngui D; Shapiro M Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819 [TBL] [Abstract][Full Text] [Related]
19. Fracture risk in early postmenopausal women assessed using FRAX. Trémollieres F; Cochet T; Cohade C; Pouillès JM; Ribot C Joint Bone Spine; 2010 Jul; 77(4):345-8. PubMed ID: 20605507 [TBL] [Abstract][Full Text] [Related]